Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas Meeting Abstract
| Authors: | Jones, R. L.; Sanfilippo, R.; Schuetze, S. M.; Sebio, A.; Alvarez, R. M.; Bui, N.; Wagner, A. J.; Chawla, S. P.; Chen, T. W. W.; Pink, D.; Le Cesne, A.; Italiano, A.; Vincenzi, B.; Kiladze, I. Z.; Patel, S.; Bryce, R.; Xu, F.; Doebele, R. C.; Schwartz, G.; Gounder, M. |
| Abstract Title: | Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S1331 |
| Language: | English |
| ACCESSION: | WOS:001087480203577 |
| DOI: | 10.1016/j.annonc.2023.10.091 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA89 -- Source: Wos |
